Evidence map›Paper›PMID 40546763›Full record

ArticleAmerican journal of lifestyle medicine2025

Executive Summary of Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine.

Richard M Rosenfeld, Meagan L Grega, Micaela C Karlsen, Abd Moain Abu Dabrh, R Nisha Aurora, Jonathan P Bonnet, Lori Donnell, Stephanie L Fitzpatrick, Beth Frates, Elizabeth A Joy and 10 more

Abstract read
In one paragraph

Article in American journal of lifestyle medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Guideline
  2. Management of brain-heart multimorbidity: a clinical practice guideline.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Guideline
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Richard M RosenfeldDepartment of Otolaryngology, SUNY Downstate Health Sciences University, Brooklyn NY, USA (RMR).ORCID https://orcid.org/0000-0002-3557-3795
Meagan L GregaDepartment of Community and Family Medicine, Kellyn Foundation, Tatamy, PA, USA (MLG).
Micaela C KarlsenDepartment of Research, American College of Lifestyle Medicine, Chesterfield, MO, USA (MCK, KLS).ORCID https://orcid.org/0000-0002-9365-151X
Abd Moain Abu DabrhDivision of Nephrology and Hypertension/Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA (AMAD).ORCID https://orcid.org/0000-0002-2481-483X
R Nisha AuroraDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, NY, USA (RNA).
Jonathan P BonnetDepartment of Medicine and Division of Primary Care and Population Health, Stanford University School of Medicine/Movietime Clinic, Palo Alto Veterans Affairs, Palo Alto, CA, USA (JPB).ORCID https://orcid.org/0000-0002-1917-0048
Lori DonnellSUNY Downstate Health Sciences University, Brooklyn, NY, USA (LD).
Stephanie L FitzpatrickNorthwell, New Hyde Park, NY, USA (SLF).
Beth FratesDepartment of Physical Medicine and Rehabilitation, Harvard Medical School/Spaulding Rehabilitation Hospital, Charlestown, MA, USA (BF).ORCID https://orcid.org/0000-0002-1156-7745
Elizabeth A JoyLore Health, San Diego, CA, USA (EAJ).ORCID https://orcid.org/0000-0002-4473-1038
Jane F KapustinRiverside Medical, Riverdale, MD, USA (JFK).
Dawn R NoeDawn Noe Nutrition and Consulting, Cleveland, OH, USA (DRN).
Gunadhar PanigrahiDepartment of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA (GP).ORCID https://orcid.org/0000-0003-4555-2725
Arun RamDepartment of Biomedical and Translational Sciences, Macon & Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USA (AR).
Lianna S Levine ReisnerPlant Powered Metro New York, New York, NY, USA (LSLR).
Willy Marcos ValenciaDepartment of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH, USA (WMV).
Lorraine J WeatherspoonDepartment of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, USA (LJW).
Jonathan M WeberDepartment of Medicine, Sections of General Internal Medicine and Endocrinology & Metabolism, Yale School of Medicine, New Haven, CT, USA (JMW).
Kara L StaffierDepartment of Research, American College of Lifestyle Medicine, Chesterfield, MO, USA (MCK, KLS).ORCID https://orcid.org/0000-0003-0998-1178
Mahima GulatiDepartment of Medicine, Division of Endocrinology, Diabetes, Metabolism, UConn Health, Farmington, CT, USA (MG).ORCID https://orcid.org/0009-0004-6726-4163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This executive summary highlights evidence-based recommendations for using lifestyle interventions in the treatment and remission of type 2 diabetes (T2D) and prediabetes in adults. The summary and guideline are intended for any clinician or healthcare professional in a community or non-inpatient healthcare setting involved in managing non-pregnant adults with T2D, prediabetes or a history of gestational diabetes mellitus (GDM). The purpose of this executive summary is to provide a succinct overview of the key action statements (recommendations) from Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline from the American College of Lifestyle Medicine. This is the first diabetes guideline to emphasize lifestyle interventions as the foundation of management and is also the first to focus on all six pillars of lifestyle medicine (plant-predomination nutrition, regular physical activity, restorative sleep, stress reduction, social connectedness, and avoiding risky substances), including behavior change strategies. This summary is not intended to substitute for the full guideline, which should be read before taking the recommended actions. The guideline on which this summary is based was developed with a priori methodology that has been previously published, refined, and used in over 20 multidisciplinary, trustworthy, and evidence-based national guidelines. The guideline development group included 20 members representing consumers, advanced practice nursing, cardiology, clinical pharmacology, behavioral medicine, endocrinology, family medicine, lifestyle medicine, nutrition and dietetics, health education, health and wellness coaching, sleep medicine, sports medicine, and obesity medicine. We developed 14 key action statements and associated evidence profiles, each with a distinct quality improvement goal in the context of lifestyle interventions for T2D. Strong recommendations were made regarding advocacy for lifestyle interventions; assessing baseline lifestyle habits; establishing priorities for lifestyle change; prescribing aerobic and muscle strength physical activity; reducing sedentary time; identifying sleep disorders; prescribing nutrition plans for prevention and treatment; promoting peer/familial support and social connections; counseling regarding tobacco, alcohol, and recreational drugs, and establishing a plan for continuity of care. Recommendations were made regarding identifying the need for psychological interventions and for adjusting (deprescribing) pharmacologic therapy. We include numerous tables and figures to facilitate implementation, a plain-language summary for consumers, and an executive summary for clinicians as separate publications. Although not a substitute for the full clinical practice guideline, this executive summary can provide insight into the key guideline recommendations, to whom they apply, and to how they might alter care. These recommendations offer detailed, explicit, and evidence-based strategies for successful lifestyle behavior change, making them relevant not only to our guideline but to other guidelines and standards that advocate for lifestyle change in managing adults with T2D.

Indexed as

behavioral medicineclinical practice guideline (CPG)evidence-based medicinegestational diabetes mellitushealth coachinglifestyle interventionslifestyle medicinenutritionprediabetesprimary care integrationsocial determinants of healthtype 2 diabetes

Identifiers

PMID40546763
PMCPMC12177839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.